months, end of June 31, 2019 Financial Statement Consolidate financial statement % revenue from sales Q2/2019 Q2/2018 increase(decrease) Q2/2019 Q2/2018 Revenues from sales 121.53 109.90 11.63 10.58
June 30, 2020, which have been reviewed by the auditor as follows: Consolidate Financial Statements Unit : Million Baht For the three-month periods ended June 30, For the six-month periods ended June 30
, end of June 30, 2020 Financial Statement Consolidate financial statement % Revenue from sales Q1/2020 Q1/2019 increase (decrease) Q1/2020 Q1/2019 Revenue from sales 85.68 121.53 (35.85) (29.50%) 100.00
equal to 0.28% of the net tangible assets by calculating from the consolidate financial statement of the Company and its subsidiaries as at December 31,2019 4 No. Contract No. Borrower Lender Appro ved
months, end of March 31, 2020 Financial Statement Consolidate financial statement % Revenue from sales Q1/2020 Q1/2019 Increase (decrease) Q1/2020 Q1/2019 Revenue from sales 45.46 67.47 (22.01 ) (32.62
million baht Size of Transaction : 32.2 million baht/ 4,903.61 million baht Size of Transaction : Size of the transaction equal to 0.66% of the net tangible assets by calculating from the consolidate
: million Baht) For 9 months, end of September 30, 2020 Financial Statement Consolidate financial statement % Revenue from sales Q3/2020 Q3/2019 increase(decrease) Q3/2020 Q3/2019 Revenue from sales 117.39
period (28.30 ) (86.38 ) 58.08 (0.67 ) Profit (loss) for the period/Total revenue (48.69%) (116.78%) Consolidate financial statement Increase (decrease) % 1. Operating revenue In summary, company and
the collective costs of doctors, nurses, and medical specialists aiming to intensify medical services and excellent specialty centers with on-going expansion striving for the Company’s growth and its